49 results on '"Murphy-Ryan M"'
Search Results
2. Assessment and Identification of Gifted Youth
3. Supplementary Table ST1 from Tumor Cell Extrinsic Synaptogyrin 3 Expression as a Diagnostic and Prognostic Biomarker in Head and Neck Cancer
4. Supplementary Table ST3 from Tumor Cell Extrinsic Synaptogyrin 3 Expression as a Diagnostic and Prognostic Biomarker in Head and Neck Cancer
5. Figure S4 from Tumor Cell Extrinsic Synaptogyrin 3 Expression as a Diagnostic and Prognostic Biomarker in Head and Neck Cancer
6. Figure S1 from Tumor Cell Extrinsic Synaptogyrin 3 Expression as a Diagnostic and Prognostic Biomarker in Head and Neck Cancer
7. Supplementary Table ST4 from Tumor Cell Extrinsic Synaptogyrin 3 Expression as a Diagnostic and Prognostic Biomarker in Head and Neck Cancer
8. Data from Tumor Cell Extrinsic Synaptogyrin 3 Expression as a Diagnostic and Prognostic Biomarker in Head and Neck Cancer
9. Figure S4 from Tumor Cell Extrinsic Synaptogyrin 3 Expression as a Diagnostic and Prognostic Biomarker in Head and Neck Cancer
10. Supplementary Table ST1 from Tumor Cell Extrinsic Synaptogyrin 3 Expression as a Diagnostic and Prognostic Biomarker in Head and Neck Cancer
11. Supplementary Table ST6 from Tumor Cell Extrinsic Synaptogyrin 3 Expression as a Diagnostic and Prognostic Biomarker in Head and Neck Cancer
12. Supplementary Table ST4 from Tumor Cell Extrinsic Synaptogyrin 3 Expression as a Diagnostic and Prognostic Biomarker in Head and Neck Cancer
13. Figure S2 from Tumor Cell Extrinsic Synaptogyrin 3 Expression as a Diagnostic and Prognostic Biomarker in Head and Neck Cancer
14. Figure S2 from Tumor Cell Extrinsic Synaptogyrin 3 Expression as a Diagnostic and Prognostic Biomarker in Head and Neck Cancer
15. Data from Tumor Cell Extrinsic Synaptogyrin 3 Expression as a Diagnostic and Prognostic Biomarker in Head and Neck Cancer
16. Supplementary Table ST5 from Tumor Cell Extrinsic Synaptogyrin 3 Expression as a Diagnostic and Prognostic Biomarker in Head and Neck Cancer
17. Figure S1 from Tumor Cell Extrinsic Synaptogyrin 3 Expression as a Diagnostic and Prognostic Biomarker in Head and Neck Cancer
18. Supplementary Table ST6 from Tumor Cell Extrinsic Synaptogyrin 3 Expression as a Diagnostic and Prognostic Biomarker in Head and Neck Cancer
19. Supplementary Table ST2 from Tumor Cell Extrinsic Synaptogyrin 3 Expression as a Diagnostic and Prognostic Biomarker in Head and Neck Cancer
20. Figure S3 from Tumor Cell Extrinsic Synaptogyrin 3 Expression as a Diagnostic and Prognostic Biomarker in Head and Neck Cancer
21. Supplementary Table ST2 from Tumor Cell Extrinsic Synaptogyrin 3 Expression as a Diagnostic and Prognostic Biomarker in Head and Neck Cancer
22. Supplementary Table ST5 from Tumor Cell Extrinsic Synaptogyrin 3 Expression as a Diagnostic and Prognostic Biomarker in Head and Neck Cancer
23. Figure S3 from Tumor Cell Extrinsic Synaptogyrin 3 Expression as a Diagnostic and Prognostic Biomarker in Head and Neck Cancer
24. Supplementary Table ST3 from Tumor Cell Extrinsic Synaptogyrin 3 Expression as a Diagnostic and Prognostic Biomarker in Head and Neck Cancer
25. Tumor Cell Extrinsic Synaptogyrin 3 Expression as a Diagnostic and Prognostic Biomarker in Head and Neck Cancer
26. Correction: TP53, CDKN2A/P16, and NFE2L2/NRF2 regulate the incidence of pure- and combined-small cell lung cancer in mice
27. Activation of the CREB Coactivator CRTC2 by Aberrant Mitogen Signaling promotes oncogenic functions in HPV16 positive head and neck cancer
28. Abstract 921: The Nrf2E79Q activating mutation accelerates growth of pure-small cell lung cancer but not combined small cell lung cancer Tp53floxed/floxed/Cdkn2afloxed/floxed mice
29. TP53, CDKN2A/P16, and NFE2L2/NRF2 regulate the incidence of pure- and combined-small cell lung cancer in mice
30. Lysyl hydroxylase 2-induced collagen cross-link switching promotes metastasis in head and neck squamous cell carcinomas
31. A conditional mouse expressing an activating mutation inNRF2displays hyperplasia of the upper gastrointestinal tract and decreased white adipose tissue
32. Gain-of-function genetic screen of the kinome reveals BRSK2 as an inhibitor of the NRF2 transcription factor
33. Gain-of-function genetic screen of the kinome reveals BRSK2 as an inhibitor of the NRF2 transcription factor
34. Rhetorical Framing and Needle Exchange in Rural Indiana: Shifting Perspectives and Policy
35. A piggyBac-based toolkit for inducible genome editing in mammalian cells
36. A piggyBac-based toolkit for inducible genome editing in mammalian cells
37. Mechanisms of Exercise Intolerance in Heart Failure With Preserved Ejection Fraction
38. Axial Loading Screw Fixation for Chevron Type Osteotomies of the Distal First Metatarsal: A Retrospective Outcomes Analysis
39. Prolonged Mean Vo 2 Response Time in Systolic Heart Failure
40. Abstract 18563: Pulmonary Artery Pressure Response Pattern in Heart Failure with Preserved Ejection Fraction
41. Exercise Oscillatory Ventilation in Heart Failure
42. Is colorectal surveillance indicated in patients with PTEN mutations?
43. DETERMINANTS OF VE/VCO2 SLOPE IN NORMAL INDIVIDUALS – VENTILATORY EFFICIENCY IS MODIFIABLE WITH ENDURANCE TRAINING
44. Exercise Oscillatory Ventilation in Systolic Heart Failure
45. Pulmonary Vascular Response Patterns During Exercise in Left Ventricular Systolic Dysfunction Predict Exercise Capacity and Outcomes
46. Oscillatory Ventilation Cycle Length and Amplitude Reflect Abnormal Exercise Hemodynamics in Systolic Heart Failure
47. Impaired Systemic Oxygen Extraction During Exercise in Heart Failure with Preserved Ejection Fraction
48. Right Ventricular and Pulmonary Vascular Response Patterns To Exercise Predict Exercise Capacity and Outcomes in Heart Failure
49. Why the “Y”? A Peculiar Intraventricular Structure Associated With a Posterior Basal Aneurysm
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.